The ZEUS Study is evaluating whether the study medicine reduces the risk of having cardiovascular events (such as a heart attack or stroke) in people with cardiovascular disease, chronic kidney disease, and inflammation. You may qualify to take part if you:
Are 18 years of age or older
Have had a stroke or heart attack, and have insufficient blood flow in your legs
Have chronic kidney disease that does not require dialysis or a transplant
Are able to attend regular clinic visits and receive phone calls for the length of the study
The ZEUS Study is evaluating whether the study medicine reduces the risk of having cardiovascular events (such as a heart attack or stroke) in people with cardiovascular disease, chronic kidney disease, and inflammation. You may qualify to take part if you:
PLEASE READ THE FOLLOWING CAREFULLY BEFORE YOU PARTICIPATE IN THE BELOW ELIGIBILITY PRE-SCREENER (THE “PRE-SCREENER”).
By participating in this Pre-Screener, I understand and agree that the questions in the Pre-Screener are designed to provide information to Clinical Trial Media (“CTM”), on behalf of Novo Nordisk, to determine my potential qualifications for an on-going research study related to Chronic Kidney Disease. My participation or non-participation in the Pre-Screener will not in any way affect any medical care I receive related to Chronic Kidney Disease. I acknowledge that the Pre-Screener is entirely voluntary and that I may change my mind about participation at any time and exit the Pre-Screener before submission.
We use cookies to optimize site functionality and give you the best experience. Necessary cookies enable core functionality. The website cannot function properly without these cookies and can only be disabled by changing your browser preferences.
For more detailed information on the cookies we use, please check our Privacy Policy.
By continuing to access this website, you are giving us consent to collect cookies.